Association of Intergenic and Intragenic MGMT Enhancer Methylation with MGMT Promoter Methylation, MGMT Protein Expression and Clinical and Demographic Parameters in Glioblastoma
International Journal of Molecular Sciences · 04.04.2025 · 26 (7) · 3390
DOI: 10.3390/ijms26073390 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.04.2025. Verfasst von Katharina Pühringer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: DNA Methylation, DNA Modification Methylases, Glioblastoma, DNA Repair Enzymes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Access Publishing Fund of the University of Vienna.
Abstract (Originalsprache)
The methylation status of the MGMT gene promoter is recognized as a key predictive biomarker for glioblastoma patients, influencing treatment decisions and outcomes. Emerging evidence suggests that enhancer methylation may also play a role in gene regulation and is associated with various clinical parameters, genetic variants, and demographic factors. This study aimed to assess DNA methylation levels in intergenic and intragenic MGMT enhancers to investigate their relationship with MGMT promoter methylation, MGMT protein expression, and clinical and demographic characteristics in glioblastoma. We developed 18 pyrosequencing assays to analyze 54 CpGs, including 34 in intergenic and 20 in intragenic enhancers. The assays were applied to tumor cells derived from 38 glioma patients. Intragenic enhancer CpGs showed significantly higher methylation than intergenic enhancer CpGs. Intragenic enhancer methylation showed a strong negative correlation with MGMT promoter methylation. For several CpGs in intragenic enhancers, an inverse L-shaped relationship between methylation levels and MGMT expression was observed. We identified distinct associations between enhancer methylation and clinical and demographic parameters. Intergenic enhancer methylation was primarily linked to the TERT SNP rs2853669 genotype, Ki-67 expression, age, and sex, whereas intragenic enhancer methylation was associated with MGMT promoter methylation, MGMT expression, overall survival, and progression-free survival. Further studies with larger patient cohorts are needed to validate the clinical relevance of intergenic and intragenic MGMT enhancer methylation in glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
- Vienna Doctoral School in Chemistry (DoSChem), University of Vienna, 1090 Vienna, Austria.
- Division of Neuropathology, Department of Pathology and Molecular Pathology, Kepler University Hospital GmbH, Johannes Kepler University, 4040 Linz, Austria.
- Clinical Research Institute for Neurosciences, Johannes Kepler University, 4020 Linz, Austria.
- Department of Neurosurgery, Kepler University Hospital GmbH, Johannes Kepler University, 4040 Linz, Austria.
ORCID-Profile: Katharina Pühringer, Philipp Czarda, Katja Zappe, Serge Weis, Margit Cichna-Markl
Förderung
- Open Access Publishing Fund of the University of Vienna
Zitieren
APA
Pühringer, K., Czarda, P., Iluca, S., Zappe, K., Weis, S., Spiegl-Kreinecker, S., & Cichna-Markl, M. (2025). Association of Intergenic and Intragenic MGMT Enhancer Methylation with MGMT Promoter Methylation, MGMT Protein Expression and Clinical and Demographic Parameters in Glioblastoma. International Journal of Molecular Sciences, 26(7), 3390. https://doi.org/10.3390/ijms26073390
Vancouver
Pühringer K, Czarda P, Iluca S, Zappe K, Weis S, Spiegl-Kreinecker S, et al. Association of Intergenic and Intragenic MGMT Enhancer Methylation with MGMT Promoter Methylation, MGMT Protein Expression and Clinical and Demographic Parameters in Glioblastoma. International Journal of Molecular Sciences. 2025;26(7):3390. doi:10.3390/ijms26073390
BibTeX
@article{Phringer2025,
author = {Pühringer, Katharina and Czarda, Philipp and Iluca, Sebastian and Zappe, Katja and Weis, Serge and Spiegl-Kreinecker, Sabine and Cichna-Markl, Margit},
title = {Association of Intergenic and Intragenic MGMT Enhancer Methylation with MGMT Promoter Methylation, MGMT Protein Expression and Clinical and Demographic Parameters in Glioblastoma},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {7},
pages = {3390},
doi = {10.3390/ijms26073390}
}
EUVIMED